drugset
drugset / Trial / NCT07550621

Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants

NCT07550621 ↗

Phase 1 Not yet recruiting 28 enrolled MindRank AI Ltd
Non-randomizedCrossoverOpen-labelBasic science

Summary

A Phase I, open-label, fixed-sequence, two-part drug-drug interaction study in healthy Chinese adults to evaluate the effect of multiple-dose rifampin (Part A) or itraconazole (Part B) on the single-dose pharmacokinetics of MDR-001, an oral GLP-1 receptor agonist.

Timeline

Start
2026-05-06
Primary completion
2026-05-31
Completion
2026-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule — —
Subject MDR-001 Small molecule — Oral
Subject Rifampin Small molecule — —

Indications

No indication recorded.